Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning and welcome to the halfway point of the week, investors! Here at InvestorPlace , we’re starting the day off like we always do with a look at the biggest pre-market stock movers. Join us as we list out t...
iBio (IBIO) shares climb nearly 20% during after-market trading on resolving its lawsuit with Fraunhofer USA.The settlement confirms iBio’s ownership of certain intellectual property related to plant-based biopharmaceutical production.As part of the settlement, iBio gran...
BRYAN, Texas, May 04, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that it has successfully resolved its lawsuit with Fraunhofer US...
iBio, Inc. is a plant-based biotechnology company and biologics contract manufacturing and development organization now undergoing a comprehensive strategy change following the March 2021 changes. iBio's management has seen very aggressive changes during 2020-2021 with a new CEO (Mar....
"Anything is on the table. Anything is possible, of course," Dr. Anthony Fauci had said in January regarding a U.S. vaccine passport, though he dispelled the notion in a Politico Dispatch podcast on Monday. "I doubt that the federal government will be the main mover of a vaccine passport conc...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The U.S. currently has three authorized and recommended vaccines, per the Centers for Disease Control and Prevention. And just as the country was roiled by the novel coronavirus, pharmaceutical stocks have had a roller-coa...
BRYAN, Texas, March 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that it will participate in the 33 rd Annual Roth Conference, which ...
Interpace Biosciences (IDXG) -28% on Nasdaq delisting.Seanergy Maritime (SHIP) -23% on capital raise.KAR Auction Services (KAR) -22% on Q4 earnings.AIkido Pharma (AIKI) -20% on capital raise.Socket Mobile (SCKT) -20%.ALJ Regional (ALJJ) -17%.Immunic (IMUX)...
Image source: The Motley Fool. iBio (NYSEMKT: IBIO) Q2 2021 Earnings Call Feb 16, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: iBio (IBIO) Q2 2021 Earnings Call Transcript
iBio, Inc. (IBIO) Q2 2021 Earnings Conference Call February 16, 2021 04:30 PM ET Company Participants Stephen Kilmer - Investor Relations Tom Isett - Chairman & Chief Executive Officer John Delta - Principal Accounting Officer Conference Call Participants Kristen Kluska - Cantor Fitzgeral...
News, Short Squeeze, Breakout and More Instantly...
– The sale of the facility eliminates $13.2M of secured debt – – Completes iBio’s transition to an AI and precision biologics innovation company - SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or th...
2024-05-28 07:30:05 ET Chardan Capital analyst issues BUY recommendation for IBIO on May 28, 2024 05:34AM ET. IBIO was trading at $2.19 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 1 - Hold recommenda...
Strengthened cash position with investment by healthcare specialist investors Expanding into cardio-metabolic space through AstralBio collaboration BRYAN, Texas and SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company...